Skip to main content

Table 6 HER2 status and median overall survival

From: Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Method for ascertaining HER2

HER2 positive

HER2 negative

Log-rank P value

CB11

11.3 months

13.1 months

0.14

FISH

10.9 months

13.1 months

0.26

HercepTest: 2–3 versus 0–1

11.5 months

13.2 months

0.84

  1. FISH, fluorescence in situ hybridization.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us